Trial Profile
The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Apr 2024
Price :
$35
*
At a glance
- Drugs BQ 788 (Primary) ; L NAME (Primary) ; PMZ-2123 (Primary) ; Sodium nitroprusside (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacodynamics
- 03 Apr 2024 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.
- 03 Apr 2024 Planned primary completion date changed from 31 Dec 2023 to 31 Dec 2024.
- 09 Mar 2023 Planned End Date changed from 31 Dec 2022 to 31 Dec 2023.